Sepetaprost
A prostaglandin analog used in glaucoma treatment
Sepetaprost | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Sepetaprost is a prostaglandin analog that has been investigated for its potential use in the treatment of glaucoma and ocular hypertension. It is a synthetic compound designed to mimic the effects of naturally occurring prostaglandins, which are lipid compounds that perform a variety of hormone-like actions in the body.
Mechanism of Action[edit | edit source]
Sepetaprost functions primarily by increasing the outflow of aqueous humor from the eye, thereby reducing intraocular pressure (IOP). This is achieved through its action on the prostaglandin F receptor, which is involved in the regulation of aqueous humor dynamics. By binding to these receptors, sepetaprost facilitates the drainage of fluid through the uveoscleral pathway, a secondary route for aqueous humor outflow.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of sepetaprost involves its absorption, distribution, metabolism, and excretion. Upon administration, sepetaprost is absorbed into the ocular tissues where it exerts its therapeutic effects. It is metabolized primarily in the liver and excreted through the kidneys. The half-life of sepetaprost in the human body is relatively short, necessitating regular dosing to maintain its therapeutic effects.
Clinical Use[edit | edit source]
Sepetaprost has been studied in clinical trials for its efficacy in lowering intraocular pressure in patients with glaucoma and ocular hypertension. These conditions are characterized by elevated IOP, which can lead to optic nerve damage and vision loss if left untreated. By reducing IOP, sepetaprost helps to prevent the progression of these diseases.
Side Effects[edit | edit source]
Common side effects associated with sepetaprost include ocular irritation, conjunctival hyperemia (redness of the eye), and changes in eyelash growth. These side effects are similar to those observed with other prostaglandin analogs used in the treatment of glaucoma.
Development and Research[edit | edit source]
Research into sepetaprost has focused on its potential advantages over existing prostaglandin analogs, such as improved efficacy or reduced side effects. Ongoing studies aim to further elucidate its safety profile and long-term effects in patients with glaucoma.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD